Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis Interventions: Drug: Pioglitazone 30mg; Drug: Empagliflozin 10 MG Sponsor: Tanta University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actos | Alcoholism | Diabetes | Empagliflozin | Endocrinology | Jardiance | Research | Study